Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$225.07 - $246.17 $690,514 - $755,249
3,068 New
3,068 $717,000
Q4 2023

Feb 13, 2024

BUY
$232.24 - $267.23 $294,944 - $339,382
1,270 New
1,270 $309,000
Q4 2022

Feb 07, 2023

BUY
$218.29 - $256.91 $185,328 - $218,116
849 Added 65.26%
2,150 $546,000
Q3 2022

Nov 07, 2022

BUY
$51.03 - $264.23 $66,390 - $343,763
1,301 New
1,301 $290,000
Q2 2022

Aug 12, 2022

SELL
$234.74 - $275.42 $721,590 - $846,641
-3,074 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$243.64 - $270.48 $748,949 - $831,455
3,074 New
3,074 $818,000
Q4 2021

Feb 09, 2022

SELL
$230.08 - $250.94 $326,023 - $355,581
-1,417 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$232.72 - $256.47 $329,764 - $363,417
1,417 New
1,417 $348,000
Q1 2021

May 17, 2021

SELL
$232.09 - $256.88 $204,703 - $226,568
-882 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$221.92 - $245.94 $195,733 - $216,919
882 New
882 $221,000
Q1 2019

Oct 17, 2019

SELL
$206.05 - $248.17 $467,115 - $562,601
-2,267 Closed
0 $0
Q4 2018

Jan 15, 2019

BUY
$204.73 - $257.93 $266,967 - $336,340
1,304 Added 135.41%
2,267 $511,000
Q3 2018

Oct 05, 2018

BUY
$233.07 - $256.0 $224,446 - $246,528
963 New
963 $251,000
Q2 2018

Jul 17, 2018

SELL
$208.1 - $233.85 $580,599 - $652,441
-2,790 Closed
0 $0
Q1 2018

Apr 17, 2018

SELL
$205.46 - $240.27 $156,765 - $183,326
-763 Reduced 21.47%
2,790 $605,000
Q4 2017

Jan 18, 2018

BUY
$189.0 - $222.64 $671,517 - $791,039
3,553
3,553 $761,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.6B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.